Superior rejection profile during the first 24 months after heart transplantation under tacrolimus as baseline immunosuppressive regimen
Matthias Helmschrott,1 Jan Beckendorf,1 Ceylan Akyol,1 Arjang Ruhparwar,2 Bastian Schmack,2 Christian Erbel,1 Christian A Gleissner,1 Mohammadreza Akhavanpoor,1 Philipp Ehlermann,1 Tom Bruckner,3 Hugo A Katus,1 Andreas O Doesch1 1Department of Cardiology, Angiology, Pneumology, University of Heide...
Main Authors: | Helmschrott M, Beckendorf J, Akyol C, Ruhparwar A, Schmack B, Erbel C, Gleissner CA, Akhavanpoor M, Ehlermann P, Bruckner T, Katus HA, Doesch AO |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-09-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | http://www.dovepress.com/superior-rejection-profile-during-the-first-24nbspmonths-after-heart-t-peer-reviewed-article-DDDT |
Similar Items
-
Advantageous effects of immunosuppression with tacrolimus in comparison with cyclosporine A regarding renal function in patients after heart transplantation
by: Helmschrott M, et al.
Published: (2015-02-01) -
Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapy
by: Rivinius R, et al.
Published: (2014-12-01) -
Conversion to generic cyclosporine A in stable chronic patients after heart transplantation
by: Kraeuter M, et al.
Published: (2013-11-01) -
Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation
by: Doesch AO, et al.
Published: (2013-10-01) -
Long-term use of amiodarone before heart transplantation significantly reduces early post-transplant atrial fibrillation and is not associated with increased mortality after heart transplantation
by: Rivinius R, et al.
Published: (2016-02-01)